{
  "created_at": "Mon Sep 20 11:20:12 +0000 2021",
  "id_str": "1439904756814782465",
  "full_text": "Pfizer and BioNTech said their Covid-19 vaccine was found to be safe and generated a strong immune response in children aged 5 to 11 years in a late-stage study https://t.co/20P6ipdQ19",
  "display_text_range": [
    0,
    184
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/20P6ipdQ19",
        "expanded_url": "https://on.wsj.com/2XwuyRo",
        "display_url": "on.wsj.com/2XwuyRo",
        "indices": [
          161,
          184
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 64,
  "favorite_count": 124,
  "possibly_sensitive": false,
  "original_created_at": "Mon Sep 20 10:50:20 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社とバイオンテック社が開発したCovid-19ワクチンは、5歳から11歳の子供を対象とした後期試験において、安全性と強い免疫反応が確認されたと発表しました。https://t.co/20P6ipdQ19"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司和BioNTech表示，他们的Covid-19疫苗在一项后期研究中被发现是安全的，并在5至11岁的儿童中产生了强烈的免疫反应 https://t.co/20P6ipdQ19"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司和BioNTech表示，他們的Covid-19疫苗在一項後期研究中被發現是安全的，並在5至11歲的兒童中產生了強烈的免疫反應 https://t.co/20P6ipdQ19"
    }
  ]
}